TORC1 Is Essential for NF1-Associated Malignancies
Top Cited Papers
- 1 January 2008
- journal article
- other
- Published by Elsevier in Current Biology
- Vol. 18 (1) , 56-62
- https://doi.org/10.1016/j.cub.2007.11.066
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- mTOR and cancer: insights into a complex relationshipNature Reviews Cancer, 2006
- Guidelines for the diagnosis and management of individuals with neurofibromatosis 1Journal of Medical Genetics, 2006
- Clinical Manifestations and Management of Neurofibromatosis Type 1Seminars in Pediatric Neurology, 2006
- Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancerNature Medicine, 2005
- The NF1 tumor suppressor critically regulates TSC2 and mTORProceedings of the National Academy of Sciences, 2005
- Proteomic Analysis Reveals Hyperactivation of the Mammalian Target of Rapamycin Pathway in Neurofibromatosis 1–Associated Human and Mouse Brain TumorsCancer Research, 2005
- Will mTOR inhibitors make it as cancer drugs?Cancer Cell, 2003
- Mouse Models of Tumor Development in Neurofibromatosis Type 1Science, 1999
- Mouse Tumor Model for Neurofibromatosis Type 1Science, 1999
- The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21Cell, 1990